Press Releases

Roche announced that the European Commission has extended the marketing authorisation for Actemra®/RoActemra® (tocilizumab) to include the treatment of COVID-19 in adults who are receiving systemic corticosteroids and require supplemental oxygen or mechanical ventilation.1 This decision comes just hours...

ATMPS Ltd/Hataali – a leader in blockchain-based data sharing platforms for advanced therapies – announces a new strategic partnership with Assurea LLC, the USA-based quality and compliance consultancy. The partnership will see Assurea and ATMPS offer a fully complaint plug...

Bachem, the Swiss-based biotechnology and pharmaceutical company, began laying the foundations for its biggest production site so far. The plant, in Bubendorf, Switzerland, will expand Bachem’s manufacturing capacity and provide the world’s most modern facility for producing peptides and...

Roquette, a global leader in plant-based ingredients and a leading provider of naturally-derived pharmaceutical excipients, announces its plans to open a new Innovation Center in the US to further the advancement of prescription drugs – and beyond. Located in...

Shanghai Pharmaceuticals and Syntegon have signed an agreement to build a laboratory for continuous manufacturing technology in China. The cooperation will promote the application of this new technology, shorten development cycles of new drugs, reduce the cost of drug...

WuXi STA – a subsidiary of WuXi AppTec– and Coherent Biopharma, announced the signing of a strategic partnership agreement. According to the agreement, WuXi STA will become the preferred CDMO partner and provide Coherent Biopharma with integrated CMC services to...

Clover Biopharmaceuticals, Ltd., a global clinical-stage biotechnology company developing novel vaccines and biologic therapeutic candidates,  announced that an investigator-led, Phase 2 trial initiated to evaluate the immunogenicity and safety of heterologous and homologous COVID-19 booster vaccines. Clover’s COVID-19 vaccine...